A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan

NCT07391761 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Multiple Myeloma (RRMM)

Interventions

DRUG: Non intervention

Sponsor

Pfizer